로딩 중…
지수 로딩 중…
FIRST TRACKS BIOTHERAPEUTICS INC
TRAX· NASDAQ· Health Care· Health Care Equipment & Services
$34.46-4.38%
2026-10-16
Financials
Valuation Metrics
FIRST TRACKS BIOTHERAPEUTICS INC's Market Cap is $1.23B. Ranked #2272 of 3,119 in US market (top 73%), #904 of 1,468 on NASDAQ (top 62%), #142 of 203 in Health Care Equipment & Services (top 70%) by Market Cap.
Investment Metrics(as of 2026-10-16)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.23B | US#2,272/3,119 Sec#142/203 |
| Revenue | $0.00 | US#2,861/3,119 Sec#201/203 |
| Net Income | $-166M | US—/3,119 Sec—/203 |
| Total Assets | $331M | US#2,885/3,119 Sec#173/203 |
| Net Assets | $287M | US#2,529/3,119 Sec#145/203 |
| Employees | 104 | US#2,605/3,119 Sec#181/203 |
| Value | ||
| P/B | 4.28x | US#2,137/3,119 Sec#120/203 |
| FCF Yield | -11.61% | US—/3,119 Sec—/203 |
| Profitability | ||
| ROE | -57.77% | US#2,707/3,119 Sec#173/203 |
| ROA | -50.25% | US#2,987/3,119 Sec#198/203 |
| Financial Health | ||
| Debt Ratio | 14.98% | US#171/3,119 Sec#14/203 |
| Total Debt | $14M | US#2,804/3,119 Sec#182/203 |
| FCF | $-143M | US#2,716/3,119 Sec#195/203 |
| Cash | $238M | US#1,600/3,119 Sec#92/203 |
| Current Ratio | 10.20x | US#244/3,119 Sec#8/203 |
| Performance | ||
| 1M Return | -11.64% | US#2,081/3,119 Sec#167/203 |
| From 52W High | -30.96% | US#1,828/3,119 Sec#132/203 |
| 1Y MDD | -39.69% | US#1,938/3,119 Sec#115/203 |
| Trading | ||
| Volume | 1,020,318 shares | US#1,174/3,119 Sec#61/203 |
| Trading Value | $36M | US#1,297/3,119 Sec#90/203 |
| Per Share | ||
| EPS | $-4.65 | US—/3,119 Sec—/203 |
| BPS | $8.05 | US#1,990/3,119 Sec#116/203 |
Company Info
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.